Medical devices; hematology and pathology devices; classification of early growth response 1 gene fluorescence in-situ hybridization test system for specimen characterization. Final order [0.03%]
医疗器械；血液学和病理学器械；标本特征早期生长反应1基因荧光原位杂交检测试剂盒分类决定书
Food and Drug Administration, HHS
Food and Drug Administration
The Food and Drug Administration (FDA) is classifying early growth response 1 (EGR1) gene fluorescence in-situ hybridization (FISH) test system for specimen characterization into class II (special controls). The special controls that will a...
Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule [0.03%]
关于苏沃雷生列为第四类受控物质的最终规定
Drug Enforcement Administration, Department of Justice
Drug Enforcement Administration
With the issuance of this final rule, the Deputy Administrator of the Drug Enforcement Administration (DEA) places the substance [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]met...
Extension of the expiration data for state disability examiner authority to make fully favorable quick disability determinations and compassionate allowances. Final rule [0.03%]
关于州一级伤残判定员作出完全有利的快速决定和同情允准权限到期日延期的最终规则
Social Security Administration
Social Security Administration
We are extending the expiration date of our rule that authorizes State agency disability examiners to make fully favorable determinations without the approval of a State agency medical or psychological consultant in claims that we consider ...
Coverage of certain preventive services under the Affordable Care Act. Interim final rules [0.03%]
关于《平价医疗法案》中某些预防性服务的保险范围。临时最终规则
Internal Revenue Service, Department of the Treasury;Employee Benefits Security Administration, Department of Labor;Centers for Medicare & Medicaid Services et al.
Internal Revenue Service et al.
This document contains interim final regulations regarding coverage of certain preventive services under section 2713 of the Public Health Service Act (PHS Act), added by the Patient Protection and Affordable Care Act, as amended, and incor...
Medical devices; clinical chemistry and clinical toxicology devices; classification of hemoglobin A1c test system. Final order [0.03%]
关于糖化血红蛋白A1c检验系统的医疗器械判定的最终命令
Food and Drug Administration, HHS
Food and Drug Administration
The Food and Drug Administration (FDA) is classifying hemoglobin A1c test system into class II (special controls). The special controls that will apply to this device are identified in this order and will be part of the codified language fo...
Medicare program; FY 2015 hospice wage index and payment rate update; hospice quality reporting requirements and process and appeals for Part D payment for drugs for beneficiaries enrolled in hospice. Final rule [0.03%]
医保项目；住院护理工资指数和支付费率更新；住院护理质量报告要求以及住院病人第D部分药物支付流程和上诉程序；最终规则
Centers for Medicare & Medicaid Services (CMS), HHS
Centers for Medicare & Medicaid Services (CMS)
This final rule will update the hospice payment rates and the wage index for fiscal year (FY) 2015 and continue the phase-out of the wage index budget neutrality adjustment factor (BNAF). This rule provides an update on hospice payment refo...
Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule [0.03%]
管制物质时间表：将含氢可酮组合制剂从第三类调整到第二类的最终规定
Drug Enforcement Administration, Department of Justice
Drug Enforcement Administration
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration reschedules hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act. This scheduling action is pursuan...
Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2015 rates; quality reporting requirements for specific providers; reasonable compensation equivalents for physician services in excluded hospitals and certain teaching hospitals; provider a [0.03%]
医疗保险程序；急性护理医院和长期护理医院住院患者分类评价支付系统及2015财年费率；特定供应商的质量报告要求；被排除的医院和某些教学医院中医生服务合理补偿等值；供应商
Centers for Medicare and Medicaid Services (CMS), HHS
Centers for Medicare and Medicaid Services (CMS)
We are revising the Medicare hospital inpatient prospective payment systems (IPPS) for operating and capital-related costs of acute care hospitals to implement changes arising from our continuing experience with these systems. Some of these...
Final priority. Rehabilitation Training: Job-Driven Vocational Rehabilitation Technical Assistance Center. Final priority [0.03%]
关于公布《以就业为导向的职业康复技术援助中心》最终优先项目的通知
Office of Special Education and Rehabilitative Services, Department of Education
Office of Special Education and Rehabilitative Services
The Assistant Secretary for Special Education and Rehabilitative Services announces a priority under the Rehabilitation Training program to establish a Job-Driven Vocational Rehabilitation Technical Assistance Center (JDVRTAC). The Assistan...
Specially adapted housing eligibility for amyotrophic lateral sclerosis beneficiaries. Final rule [0.03%]
肌萎缩侧索硬化症受益人的专门适应性住房资格规定 最终规则
Department of Veterans Affairs
Department of Veterans Affairs
The Department of Veterans Affairs (VA) amended by interim final rule its adjudication regulation regarding specially adapted housing (SAH) to authorize automatic issuance of a certificate of eligibility for SAH to all veterans and active-d...